264 related articles for article (PubMed ID: 30987839)
1. Preclinical Development of a vWF Aptamer to Limit Thrombosis and Engender Arterial Recanalization of Occluded Vessels.
Nimjee SM; Dornbos D; Pitoc GA; Wheeler DG; Layzer JM; Venetos N; Huttinger A; Talentino SE; Musgrave NJ; Moody H; Rempel RE; Jones C; Carlisle K; Wilson J; Bratton C; Joseph ME; Khan S; Hoffman MR; Sommerville L; Becker RC; Zweier JL; Sullenger BA
Mol Ther; 2019 Jul; 27(7):1228-1241. PubMed ID: 30987839
[TBL] [Abstract][Full Text] [Related]
2. Antidote-controlled platelet inhibition targeting von Willebrand factor with aptamers.
Oney S; Nimjee SM; Layzer J; Que-Gewirth N; Ginsburg D; Becker RC; Arepally G; Sullenger BA
Oligonucleotides; 2007; 17(3):265-74. PubMed ID: 17854267
[TBL] [Abstract][Full Text] [Related]
3. Potent Thrombolytic Effect of
Martinez de Lizarrondo S; Gakuba C; Herbig BA; Repessé Y; Ali C; Denis CV; Lenting PJ; Touzé E; Diamond SL; Vivien D; Gauberti M
Circulation; 2017 Aug; 136(7):646-660. PubMed ID: 28487393
[TBL] [Abstract][Full Text] [Related]
4. Targeting von Willebrand factor as a novel anti-platelet therapy; application of ARC1779, an Anti-vWF aptamer, against thrombotic risk.
Bae ON
Arch Pharm Res; 2012 Oct; 35(10):1693-9. PubMed ID: 23139119
[TBL] [Abstract][Full Text] [Related]
5. P-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor.
Diaz JA; Wrobleski SK; Alvarado CM; Hawley AE; Doornbos NK; Lester PA; Lowe SE; Gabriel JE; Roelofs KJ; Henke PK; Schaub RG; Wakefield TW; Myers DD
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):829-37. PubMed ID: 25657307
[TBL] [Abstract][Full Text] [Related]
6. ARC-1779, a PEGylated aptamer antagonist of von Willebrand factor for potential use as an anticoagulant or antithrombotic agent.
Cosmi B
Curr Opin Mol Ther; 2009 Jun; 11(3):322-8. PubMed ID: 19479665
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779.
Diener JL; Daniel Lagassé HA; Duerschmied D; Merhi Y; Tanguay JF; Hutabarat R; Gilbert J; Wagner DD; Schaub R
J Thromb Haemost; 2009 Jul; 7(7):1155-62. PubMed ID: 19422452
[TBL] [Abstract][Full Text] [Related]
8. Rapidly regulating platelet activity in vivo with an antidote controlled platelet inhibitor.
Nimjee SM; Lohrmann JD; Wang H; Snyder DJ; Cummings TJ; Becker RC; Oney S; Sullenger BA
Mol Ther; 2012 Feb; 20(2):391-7. PubMed ID: 22086230
[TBL] [Abstract][Full Text] [Related]
9. The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin.
Kovacevic KD; Buchtele N; Schoergenhofer C; Derhaschnig U; Gelbenegger G; Brostjan C; Zhu S; Gilbert JC; Jilma B
Sci Rep; 2020 Jul; 10(1):11180. PubMed ID: 32636459
[TBL] [Abstract][Full Text] [Related]
10. An anti-von Willebrand factor aptamer reduces platelet adhesion among patients receiving aspirin and clopidogrel in an ex vivo shear-induced arterial thrombosis.
Arzamendi D; Dandachli F; Théorêt JF; Ducrocq G; Chan M; Mourad W; Gilbert JC; Schaub RG; Tanguay JF; Merhi Y
Clin Appl Thromb Hemost; 2011; 17(6):E70-8. PubMed ID: 21078615
[TBL] [Abstract][Full Text] [Related]
11. The chimeric monoclonal antibody MHCSZ-123 against human von Willebrand factor A3 domain inhibits high-shear arterial thrombosis in a Rhesus monkey model.
Ji S; Jiang M; Yan B; Shen F; He Y; Wan A; Xia L; Ruan C; Zhao Y
J Hematol Oncol; 2017 May; 10(1):111. PubMed ID: 28526067
[TBL] [Abstract][Full Text] [Related]
12. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
[TBL] [Abstract][Full Text] [Related]
13. The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction.
Spiel AO; Mayr FB; Ladani N; Wagner PG; Schaub RG; Gilbert JC; Jilma B
Platelets; 2009 Aug; 20(5):334-40. PubMed ID: 19637097
[TBL] [Abstract][Full Text] [Related]
14. Magnesium maintains endothelial integrity, up-regulates proteolysis of ultra-large von Willebrand factor, and reduces platelet aggregation under flow conditions.
Dong JF; Cruz MA; Aboulfatova K; Martin C; Choi H; Bergeron AL; Martini SR; Kroll MH; Kent TA
Thromb Haemost; 2008 Mar; 99(3):586-93. PubMed ID: 18327408
[TBL] [Abstract][Full Text] [Related]
15. A new approach to antiplatelet therapy: inhibitor of GPIb/V/IX-vWF interaction.
Ikeda Y; Handa M; Murata M; Goto S
Haemostasis; 2000; 30 Suppl 3():44-52. PubMed ID: 11182627
[TBL] [Abstract][Full Text] [Related]
16. Anti-human VWF monoclonal antibody SZ-123 prevents arterial thrombus formation by inhibiting VWF-collagen and VWF-platelet interactions in Rhesus monkeys.
Zhao YM; Jiang M; Ji SD; He Y; Shen F; Li XM; Ruan CG
Biochem Pharmacol; 2013 Apr; 85(7):945-53. PubMed ID: 23295157
[TBL] [Abstract][Full Text] [Related]
17. Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs.
De Meyer SF; Vanhoorelbeke K; Ulrichts H; Staelens S; Feys HB; Salles I; Fontayne A; Deckmyn H
Cardiovasc Hematol Disord Drug Targets; 2006 Sep; 6(3):191-207. PubMed ID: 17017902
[TBL] [Abstract][Full Text] [Related]
18. A murine model to characterize the antithrombotic effect of molecules targeting human von Willebrand factor.
Navarrete AM; Casari C; Legendre P; Marx I; Hu JR; Lenting PJ; Christophe OD; Denis CV
Blood; 2012 Sep; 120(13):2723-32. PubMed ID: 22915646
[TBL] [Abstract][Full Text] [Related]
19. Potent and rapid reversal of the von Willebrand factor inhibitor aptamer BT200.
Zhu S; Gilbert JC; Liang Z; Kang D; Li M; Tarantino PM; Jilma B
J Thromb Haemost; 2020 Jul; 18(7):1695-1704. PubMed ID: 32275107
[TBL] [Abstract][Full Text] [Related]
20. The development and characterization of a long acting anti-thrombotic von Willebrand factor (VWF) aptamer.
Zhu S; Gilbert JC; Hatala P; Harvey W; Liang Z; Gao S; Kang D; Jilma B
J Thromb Haemost; 2020 May; 18(5):1113-1123. PubMed ID: 32011054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
